Replication analysis in an independent ovarian serous cancer cohort following treatment with platinum antineoplastic agents using the Kaplan–Meier survival curve plotter demonstrated that low expression of VCP was associated with poor progression-free survival (p = 0.015) and shorter median survival time (Fig. 2a). This evidence concerns the gene VCP and ovarian serous adenocarcinoma.